ADVERUM BIOTECHNOLOGIES INC (ADVM) Stock Balance Sheet
NASDAQ:ADVM - Nasdaq - US00773U2078 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 92.85M | 75.00M | 68.43M | 34.20M | 62.42M | |||
| Marketable Securities | 60.39M | 21.53M | 117.16M | 270.99M | 367.31M | |||
| Receivables | N/A | N/A | 0.00 | 5.71M | N/A | |||
| Other Current Assets | 7.84M | 6.25M | 5.01M | 6.25M | 4.71M | |||
| Total Current Assets | 161.08M | 102.77M | 190.59M | 317.14M | 434.44M | |||
| Non-Current Assets | ||||||||
| PPE Net | 62.91M | 67.03M | 113.86M | 119.06M | 47.10M | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 3.27M | 3.21M | 3.92M | 2.75M | 1.03M | |||
| Total Non-Current Assets | 73.30M | 70.24M | 117.78M | 122.58M | 48.13M | |||
| TOTAL ASSETS | 234.38M | 173.01M | 308.37M | 439.73M | 482.57M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 25.55M | 22.89M | 29.75M | 18.61M | 18.06M | |||
| Accounts Payable | 2.11M | 1.92M | 2.24M | 1.39M | 2.81M | |||
| Other Current Liabilities | N/A | 101.00K | 254.00K | 1.32M | N/A | |||
| Total Current Liabilities | 27.66M | 24.91M | 32.25M | 21.32M | 20.87M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 62.60M | 64.63M | 94.61M | 102.22M | 27.35M | |||
| Total Non-Current Liabilities | 62.60M | 64.63M | 94.61M | 102.22M | 27.35M | |||
| TOTAL LIABILITIES | 90.26M | 89.54M | 126.85M | 123.54M | 48.22M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -990.17M | -919.78M | -802.61M | -648.08M | -502.54M | |||
| Additional Paid In Capital | 1.13B | 1.00B | 985.65M | 964.97M | 937.13M | |||
| Common Shares | 2.00K | 10.00K | 10.00K | 10.00K | 10.00K | |||
| Other Shareholders' Equity | -268.00K | -473.00K | -1.53M | -714.00K | -261.00K | |||
| Shares Outstanding | 20.80M | 10.14M | 10.01M | 9.84M | 9.76M | |||
| Tangible Book Value per Share | 6.93 | 8.23 | 18.13 | 32.14 | 44.53 | |||
| Total Shareholders' Equity | 144.12M | 83.47M | 181.52M | 316.19M | 434.35M | |||
| TOTAL LIABILITIES AND EQUITY | 234.38M | 173.01M | 308.37M | 439.73M | 482.57M | |||
| Statistics | ||||||||
| Current Ratio | 5.82 | 4.13 | 5.91 | 14.88 | 20.82 | |||
| Return On Assets (ROA) | -40.15% | -67.72% | -50.11% | -33.10% | -24.35% | |||
| Return On Equity (ROE) | -65.30% | -140.37% | -85.14% | -46.03% | -27.05% | |||
All data in USD , ROIC based on taxRate of 0.21